Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compared the Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 With Calcium Carbonate in Hemodialysis Patients

NCT01845090 is registered in ClinicalTrials.gov with Camillians Saint Mary's Hospital Luodong as lead sponsor.

NCT NCT01845090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compared the Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 With Calcium Carbonate in Hemodialysis Patients
Lead sponsor
Camillians Saint Mary's Hospital Luodong
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2011
Completion date
July 31, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

other nonspecific abnormal serum enzyme levels